What is the recommended dose for heparin (unfractionated heparin) perfusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Heparin Perfusion Dosing

For venous thromboembolism (VTE), the recommended heparin perfusion dose is an initial bolus of 80 units/kg followed by a continuous infusion of 18 units/kg/hour, with dose adjustments based on aPTT monitoring. 1

Initial Dosing Recommendations by Indication

For Venous Thromboembolism (DVT/PE):

  • Initial bolus: 80 units/kg IV (maximum not specified in guidelines)
  • Initial infusion: 18 units/kg/hour 1
  • Alternative fixed-dose approach: 5,000 units IV bolus followed by infusion of at least 32,000 units/day 1

For Acute Coronary Syndromes:

  • Initial bolus: 60-70 units/kg IV (maximum 5,000 units)
  • Initial infusion: 12-15 units/kg/hour (maximum 1,000 units/hour) 1

For ST-Elevation Myocardial Infarction with Fibrinolytic Therapy:

  • Initial bolus: 60 units/kg IV (maximum 4,000 units)
  • Initial infusion: 12 units/kg/hour (maximum 1,000 units/hour) 1

Monitoring and Dose Adjustment

The FDA label recommends adjusting heparin dosage according to coagulation test results, with a target aPTT of 1.5-2 times normal (approximately 50-70 seconds) 2. This therapeutic range is based on evidence showing that patients who achieved therapeutic aPTT in less than 24 hours had lower mortality rates 1.

aPTT-Based Dose Adjustment Protocol:

aPTT (seconds) Bolus (U/kg) Hold (min) Rate Change Repeat aPTT
< 50 50 0 ↑ 10% 4 hours
50-59 0 0 ↑ 10% 4 hours
60-85 (target) 0 0 No change Next day
86-95 0 0 ↓ 10% 4 hours
96-120 0 30 ↓ 10% 4 hours
> 120 0 60 ↓ 15% 4 hours
[3]

Special Considerations

Obesity:

  • Standard weight-based protocols with maximum doses can lead to significant delays in achieving therapeutic anticoagulation in obese patients 4
  • Underdosing is common in obese patients, with 89% receiving lower than recommended bolus doses and 76% receiving inadequate initial infusions 4

Pediatric Patients:

  • Initial bolus: 75-100 units/kg IV over 10 minutes
  • Maintenance infusion:
    • Infants < 1 year: 28 units/kg/hour
    • Children > 1 year: 18-20 units/kg/hour 3
  • Target aPTT: 60-85 seconds 3

Cardiovascular Surgery:

  • Initial dose: Minimum 150 units/kg
  • For procedures < 60 minutes: 300 units/kg
  • For procedures > 60 minutes: 400 units/kg 2

Dialysis:

  • Initial dose: 25-30 units/kg
  • Maintenance infusion: 1,500-2,000 units/hour 2

Pitfalls and Caveats

  1. Delayed Therapeutic Effect: A significant proportion of patients (29%) may take more than 24 hours to achieve therapeutic anticoagulation, especially if underdosed 4

  2. Weight-Based vs. Fixed Dosing: Weight-based dosing has been shown to achieve therapeutic anticoagulation more quickly and effectively than fixed dosing, with lower rates of recurrent thromboembolism 1

  3. Monitoring Frequency: When initiating treatment with continuous infusion, check aPTT at baseline and approximately every 4 hours until stable, then at appropriate intervals 2

  4. Bleeding Risk: Risk increases with higher heparin doses, concomitant use of fibrinolytic agents or glycoprotein IIb/IIIa inhibitors, recent surgery/trauma, and in patients with comorbidities, age >60 years, or hepatic dysfunction 1

  5. Platelet Monitoring: Regular monitoring of platelet count is essential to detect heparin-induced thrombocytopenia 3

By following these evidence-based dosing recommendations and monitoring protocols, you can optimize the efficacy and safety of heparin perfusion therapy for your patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Heparin Therapy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.